PUBLISHER: TechNavio | PRODUCT CODE: 1788476
PUBLISHER: TechNavio | PRODUCT CODE: 1788476
The AI in cardiology market is forecasted to grow by USD 10,381.7 mn during 2024-2029, accelerating at a CAGR of 46.1% during the forecast period. The report on the AI in cardiology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by proliferation and increasing complexity of cardiovascular data, mounting pressure on healthcare systems to enhance efficiency, control costs, and improve outcomes, and increasingly favorable regulatory landscape and growing body of clinical validation.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 39% |
CAGR | 46.1% |
Incremental Value | $10,381.7 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's AI in cardiology market is segmented as below:
By Component
By Type
By Application
By Geographical Landscape
This study identifies the emergence of multimodal AI and foundation models for holistic patient assessment as one of the prime reasons driving the AI in cardiology market growth during the next few years. Also, decentralization of AI to point of care and edge devices and application of generative AI in drug discovery and personalized treatment simulation will lead to sizable demand in the market.
The report on the AI in cardiology market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading AI in cardiology market vendors that include Aidoc, AliveCor Inc., Biofourmis Inc., Caption Care, Cardiologs, Cleerly Inc., Eko Devices Inc., HeartFlow Inc., Imricor, Merative L.P., Nano-X Imaging Ltd., Perspectum Ltd, RSIP VISION LTD, Siemens Healthineers AG, Tempus Labs Inc., UltraSight Ltd, Ultromics Ltd., Vista AI Inc., and ZEBRA MEDICAL. Also, the AI in cardiology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: